---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-091783"
form_type: "8-K"
ticker: "SILO"
cik: "0001514183"
company_name: "Silo Pharma, Inc."
filed_at: "2026-08-19T21:17:23+00:00"
generated_at: "2026-08-19T21:18:09.574782+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Silo Pharma acquires software assets for 165k shares; seller is affiliate advisor

## Summary
- Asset purchase agreement dated Aug 18, 2026 with Parkview Consulting LLC; consideration is 165,000 common shares (par $0.0001).
- Assets include software "Reputation Endpoints" with full source/object code and related IP; seller is Corwin Yu, lead strategic advisor on Silo's Crypto Advisory Board.
- Shares subject to 12-month lock-up, ending earlier on change of control or company consent; sale exempt under Section 4(a)(2).
- Seller indemnifies for misrepresentation, IP infringement, gross negligence/fraud; reps survive 12 months.
- Agreement governed by New York law; transaction closed effective August 18, 2026.

## SEC filing metadata
- accession: 0001213900-26-091783
- form_type: 8-K
- ticker: SILO
- cik: 0001514183
- company_name: Silo Pharma, Inc.
- filed_at: 2026-08-19T21:17:23+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1514183/000121390026091783/0001213900-26-091783-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1514183/000121390026091783/ea0302618-8k_silo.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-091783
- JSON: https://secwatch.observer/filing/0001213900-26-091783.json
- Plain text: https://secwatch.observer/filing/0001213900-26-091783.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.